According to Phibro Animal Health
's latest financial reports the company has $92.49 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-06-30 | $81.28 M | -10.92% |
2022-06-30 | $91.24 M | -2.11% |
2021-06-30 | $93.21 M | 2.05% |
2020-06-30 | $91.34 M | 11.98% |
2019-06-30 | $81.57 M | 3.04% |
2018-06-30 | $79.16 M | 41.16% |
2017-06-30 | $56.08 M | 66.89% |
2016-06-30 | $33.6 M | 15.02% |
2015-06-30 | $29.21 M | 147.15% |
2014-06-30 | $11.82 M | -56.81% |
2013-06-30 | $27.36 M | -49.22% |
2012-06-30 | $53.9 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | $2.92 B | 3,065.32% | ๐บ๐ธ USA |
Archer Daniels Midland (ADM)
ADM | $1.36 B | 1,379.03% | ๐บ๐ธ USA |
Zoetis ZTS | $2.03 B | 2,104.49% | ๐บ๐ธ USA |
Merck MRK | $7.09 B | 7,568.69% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | N/A | N/A | ๐บ๐ธ USA |
Heska Corporation
HSKA | $0.12 B | 35.37% | ๐บ๐ธ USA |